3 Reasons AbbVie Investors Aren't Too Worried About Humira Anymore - Motley Fool

3 Reasons AbbVie Investors Aren't Too Worried About Humira Anymore  Motley Fool

AbbVie (NYSE:ABBV) investors have been dreading this moment since the company's inception in 2013. International Humira sales tumbled during the fourth ...